Effect of ramipril on mitral regurgitation secondary to mitral valve prolapse

Am J Cardiol. 1997 Sep 1;80(5):655-8. doi: 10.1016/s0002-9149(97)00445-1.

Authors

U Høst¹, H Kelbaek, P Hildebrandt, K Skagen, J Aldershvile

Affiliation

¹ Department of Medicine B, Rigshospitalet, Herlev Hospital, University of Copenhagen, Denmark.

PMID: 9295005
DOI: 10.1016/s0002-9149(97)00445-1

Abstract

Ramipril 10 mg/day reduced regurgitation in chronic mitral regurgitation secondary to mitral valve prolapse in patients with sinus rhythm.

Publication types

Clinical Trial
Randomized Controlled Trial

MeSH terms

Adult
Aged
Angiotensin-Converting Enzyme Inhibitors / pharmacology
Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
Chordae Tendineae
Cross-Over Studies
Female
Hemodynamics / drug effects
Humans
Male
Middle Aged
Mitral Valve Insufficiency / drug therapy*
Mitral Valve Insufficiency / etiology
Mitral Valve Prolapse / complications*
Ramipril / pharmacology
Ramipril / therapeutic use*
Rupture
Ventricular Function, Left / drug effects*

Substances

Angiotensin-Converting Enzyme Inhibitors
Ramipril